A comparison of premeal subcutaneous insulin infusion and injection in type I diabetic patients under continuous basal subcutaneous insulin delivery.Life Support Syst. 1985 Jul-Sep; 3(3):263-7.LS
Abstract
Blood glucose control under continuous subcutaneous insulin infusion (CSII) was assessed in five type I diabetic patients by measurement of mean blood glucose and M-values. These results were compared with the data obtained from treatment with constant basal subcutaneous insulin delivery supplemented by injection of regular insulin before meals into changing sites of the anterior abdominal wall. CSII treatment gave significantly (P less than 0.05) better results. It might be assumed that this is due to the more reliable insulin absorption from an unchanged site.
MeSH
Pub Type(s)
Comparative Study
Journal Article
Research Support, Non-U.S. Gov't
Language
eng
PubMed ID
3900596
Citation
Navascués, I, et al. "A Comparison of Premeal Subcutaneous Insulin Infusion and Injection in Type I Diabetic Patients Under Continuous Basal Subcutaneous Insulin Delivery." Life Support Systems : the Journal of the European Society for Artificial Organs, vol. 3, no. 3, 1985, pp. 263-7.
Navascués I, Kerner W, Pfeiffer EF. A comparison of premeal subcutaneous insulin infusion and injection in type I diabetic patients under continuous basal subcutaneous insulin delivery. Life Support Syst. 1985;3(3):263-7.
Navascués, I., Kerner, W., & Pfeiffer, E. F. (1985). A comparison of premeal subcutaneous insulin infusion and injection in type I diabetic patients under continuous basal subcutaneous insulin delivery. Life Support Systems : the Journal of the European Society for Artificial Organs, 3(3), 263-7.
Navascués I, Kerner W, Pfeiffer EF. A Comparison of Premeal Subcutaneous Insulin Infusion and Injection in Type I Diabetic Patients Under Continuous Basal Subcutaneous Insulin Delivery. Life Support Syst. 1985 Jul-Sep;3(3):263-7. PubMed PMID: 3900596.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - A comparison of premeal subcutaneous insulin infusion and injection in type I diabetic patients under continuous basal subcutaneous insulin delivery.
AU - Navascués,I,
AU - Kerner,W,
AU - Pfeiffer,E F,
PY - 1985/7/1/pubmed
PY - 1985/7/1/medline
PY - 1985/7/1/entrez
SP - 263
EP - 7
JF - Life support systems : the journal of the European Society for Artificial Organs
JO - Life Support Syst
VL - 3
IS - 3
N2 - Blood glucose control under continuous subcutaneous insulin infusion (CSII) was assessed in five type I diabetic patients by measurement of mean blood glucose and M-values. These results were compared with the data obtained from treatment with constant basal subcutaneous insulin delivery supplemented by injection of regular insulin before meals into changing sites of the anterior abdominal wall. CSII treatment gave significantly (P less than 0.05) better results. It might be assumed that this is due to the more reliable insulin absorption from an unchanged site.
SN - 0261-989X
UR - https://www.unboundmedicine.com/medline/citation/3900596/A_comparison_of_premeal_subcutaneous_insulin_infusion_and_injection_in_type_I_diabetic_patients_under_continuous_basal_subcutaneous_insulin_delivery_
DB - PRIME
DP - Unbound Medicine
ER -